Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency

Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disorder caused by mutations in the gene-encoding acid sphingomyelinase (ASM). ASMD impacts peripheral organs in all patients, including the liver and spleen. The infantile and chronic neurovisceral forms of the disease also lead to neur...

Full description

Bibliographic Details
Main Authors: Ángel Gaudioso, Pilar Moreno-Huguet, Josefina Casas, Edward H. Schuchman, María Dolores Ledesma
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/11/9756
_version_ 1797597323923030016
author Ángel Gaudioso
Pilar Moreno-Huguet
Josefina Casas
Edward H. Schuchman
María Dolores Ledesma
author_facet Ángel Gaudioso
Pilar Moreno-Huguet
Josefina Casas
Edward H. Schuchman
María Dolores Ledesma
author_sort Ángel Gaudioso
collection DOAJ
description Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disorder caused by mutations in the gene-encoding acid sphingomyelinase (ASM). ASMD impacts peripheral organs in all patients, including the liver and spleen. The infantile and chronic neurovisceral forms of the disease also lead to neuroinflammation and neurodegeneration for which there is no effective treatment. Cellular accumulation of sphingomyelin (SM) is a pathological hallmark in all tissues. SM is the only sphingolipid comprised of a phosphocholine group linked to ceramide. Choline is an essential nutrient that must be obtained from the diet and its deficiency promotes fatty liver disease in a process dependent on ASM activity. We thus hypothesized that choline deprivation could reduce SM production and have beneficial effects in ASMD. Using acid sphingomyelinase knock-out (ASMko) mice, which mimic neurovisceral ASMD, we have assessed the safety of a choline-free diet and its effects on liver and brain pathological features such as altered sphingolipid and glycerophospholipid composition, inflammation and neurodegeneration. We found that the choline-free diet was safe in our experimental conditions and reduced activation of macrophages and microglia in the liver and brain, respectively. However, there was no significant impact on sphingolipid levels and neurodegeneration was not prevented, arguing against the potential of this nutritional strategy to assist in the management of neurovisceral ASMD patients.
first_indexed 2024-03-11T03:04:46Z
format Article
id doaj.art-890df6f38453443583dfc676d7378a27
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T03:04:46Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-890df6f38453443583dfc676d7378a272023-11-18T08:03:42ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-06-012411975610.3390/ijms24119756Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase DeficiencyÁngel Gaudioso0Pilar Moreno-Huguet1Josefina Casas2Edward H. Schuchman3María Dolores Ledesma4Centro Biologia Molecular Severo Ochoa (CSIC-UAM), 28049 Madrid, SpainCentro Biologia Molecular Severo Ochoa (CSIC-UAM), 28049 Madrid, SpainRUBAM, IQAC-CSIC & CIBEREHD, 08034 Barcelona, SpainIcahn School of Medicine at Mount Sinai, New York, NY 10029, USACentro Biologia Molecular Severo Ochoa (CSIC-UAM), 28049 Madrid, SpainAcid sphingomyelinase deficiency (ASMD) is a lysosomal storage disorder caused by mutations in the gene-encoding acid sphingomyelinase (ASM). ASMD impacts peripheral organs in all patients, including the liver and spleen. The infantile and chronic neurovisceral forms of the disease also lead to neuroinflammation and neurodegeneration for which there is no effective treatment. Cellular accumulation of sphingomyelin (SM) is a pathological hallmark in all tissues. SM is the only sphingolipid comprised of a phosphocholine group linked to ceramide. Choline is an essential nutrient that must be obtained from the diet and its deficiency promotes fatty liver disease in a process dependent on ASM activity. We thus hypothesized that choline deprivation could reduce SM production and have beneficial effects in ASMD. Using acid sphingomyelinase knock-out (ASMko) mice, which mimic neurovisceral ASMD, we have assessed the safety of a choline-free diet and its effects on liver and brain pathological features such as altered sphingolipid and glycerophospholipid composition, inflammation and neurodegeneration. We found that the choline-free diet was safe in our experimental conditions and reduced activation of macrophages and microglia in the liver and brain, respectively. However, there was no significant impact on sphingolipid levels and neurodegeneration was not prevented, arguing against the potential of this nutritional strategy to assist in the management of neurovisceral ASMD patients.https://www.mdpi.com/1422-0067/24/11/9756cholinesphingomyelinlysosomal storage disorderlipidomicacid sphingomyelinase deficiencyphospholipid
spellingShingle Ángel Gaudioso
Pilar Moreno-Huguet
Josefina Casas
Edward H. Schuchman
María Dolores Ledesma
Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency
International Journal of Molecular Sciences
choline
sphingomyelin
lysosomal storage disorder
lipidomic
acid sphingomyelinase deficiency
phospholipid
title Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency
title_full Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency
title_fullStr Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency
title_full_unstemmed Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency
title_short Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency
title_sort modulation of dietary choline uptake in a mouse model of acid sphingomyelinase deficiency
topic choline
sphingomyelin
lysosomal storage disorder
lipidomic
acid sphingomyelinase deficiency
phospholipid
url https://www.mdpi.com/1422-0067/24/11/9756
work_keys_str_mv AT angelgaudioso modulationofdietarycholineuptakeinamousemodelofacidsphingomyelinasedeficiency
AT pilarmorenohuguet modulationofdietarycholineuptakeinamousemodelofacidsphingomyelinasedeficiency
AT josefinacasas modulationofdietarycholineuptakeinamousemodelofacidsphingomyelinasedeficiency
AT edwardhschuchman modulationofdietarycholineuptakeinamousemodelofacidsphingomyelinasedeficiency
AT mariadoloresledesma modulationofdietarycholineuptakeinamousemodelofacidsphingomyelinasedeficiency